Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations
Publication
, Conference
Ark, J; Nyberg, W; Havlik, P; To, A; Eyquem, J; Asokan, A
Published in: MOLECULAR THERAPY
2021
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2021
Volume
29
Issue
4
Start / End Page
32 / 32
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ark, J., Nyberg, W., Havlik, P., To, A., Eyquem, J., & Asokan, A. (2021). Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations. In MOLECULAR THERAPY (Vol. 29, pp. 32–32).
Ark, Jonathan, William Nyberg, Patrick Havlik, Angela To, Justin Eyquem, and Aravind Asokan. “Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations.” In MOLECULAR THERAPY, 29:32–32, 2021.
Ark J, Nyberg W, Havlik P, To A, Eyquem J, Asokan A. Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations. In: MOLECULAR THERAPY. 2021. p. 32–32.
Ark, Jonathan, et al. “Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations.” MOLECULAR THERAPY, vol. 29, no. 4, 2021, pp. 32–32.
Ark J, Nyberg W, Havlik P, To A, Eyquem J, Asokan A. Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations. MOLECULAR THERAPY. 2021. p. 32–32.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2021
Volume
29
Issue
4
Start / End Page
32 / 32
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences